| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3943663 | Gynecologic Oncology | 2006 | 8 Pages |
Abstract
In patients with histopathologically confirmed stage IVA cervical cancer primary, exenteration is a valid alternative to primary chemoradiation. In patients with persistent or recurrent tumor limited to the pelvis, secondary exenteration should be offered in the absence of other therapeutic options. Palliative and curative attempts can best be differentiated by the resection margin status.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Simone Marnitz, Christhardt Köhler, Marianne Müller, Katja Behrens, Kati Hasenbein, Achim Schneider,